CART-AI-Radiomics: Survival and Neurotoxicity Prediction in B-Cell Lymphoma Patients Treated with CAR-T Cells through an Imaging Features-Based Model

Authors:

Abstract
Disclosures. Hernandez Boluda:Pfizer, BMS, Incyte, and Novartis: Membership on an entity's Board of Directors or advisory committees. Guerreiro:Novartis, Kite,